Outsourcing-pharma9d
Ethris reports positive phase 1 results for asthma mRNA therapy
Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...
Outsourcing-pharma11d
Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials
Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...
Outsourcing-pharma11d
Manas AI bags $24.6 million to turbocharge drug discovery
Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.
Outsourcing-pharma11d
Women in Science: Émilie Barré on her passion for applying data to real-world challenges
Throughout her career, One2Treat’s Émilie Barré has focused on developing both the analytical and leadership aspects ...
Outsourcing-pharma10d
Lantheus to acquire Evergreen in $1bn deal to expand radiopharmaceutical pipeline
Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...
Outsourcing-pharma16d
Arctic Therapeutics to tackle dementia and skin disease with €26.5 million series A
Arctic Therapeutics announced this week that it has raised €26.5 million, a sum bankrolled by investors including the European Innovation Council (EIC) Fund, the Icelandic investment firm Kaldbakur ...
Outsourcing-pharma23d
Transforming research through patient-centric design and innovation
The evolution of clinical trials is being driven by an increased focus on patient perspectives and innovative statistical methodologies. Regulatory agencies are pushing for trials that better ...